NSE - Delayed Quote INR

NATCO Pharma Limited (NATCOPHARM.NS)

881.65
+18.55
+(2.15%)
At close: 3:29:59 PM GMT+5:30

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 12.21B
Earnings 4.07B

Q2'24

Q3'24

Q4'24

Q1'25

0
5B
10B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

697.00 Low
961.55 Average
881.65 Current
1,480.00 High

Earnings Estimate

Currency in INR Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2026)Next Year (2027)
No. of Analysts 11811
Avg. Estimate 35.415.969.837.09
Low Estimate 35.415.940.825.2
High Estimate 35.415.980.545.6
Year Ago EPS 37.3237.81105.2669.8

Revenue Estimate

Currency in INR Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2026)Next Year (2027)
No. of Analysts 11810
Avg. Estimate 14.78B9.6B38.04B29.76B
Low Estimate 14.78B9.6B36.18B21.95B
High Estimate 14.78B9.6B42.16B43.33B
Year Ago Sales 13.63B13.71B44.3B38.04B
Sales Growth (year/est) 8.49%-29.99%-14.12%-21.77%

Earnings History

Currency in INR 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. 4231.513.3634.05
EPS Actual 37.3237.817.4322.7
Difference -4.686.31-5.93-11.35
Surprise % -11.14%20.03%-44.39%-33.33%

EPS Trend

Currency in INR Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2026)Next Year (2027)
Current Estimate 35.415.969.837.09
7 Days Ago 0074.1537.05
30 Days Ago 00106.2939.65
60 Days Ago 00104.5539.65
90 Days Ago 00104.7139.72

EPS Revisions

Currency in INR Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2026)Next Year (2027)
Up Last 7 Days ------1
Up Last 30 Days --------
Down Last 7 Days ----86
Down Last 30 Days ----76

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
NATCOPHARM.NS -5.14%-57.95%-33.69%-46.86%
S&P 500 13.13%2.46%7.55%14.08%

Related Tickers